A method for predicting yield and composition changes during urea inclusion fractionation to select a fatty acid methyl ester source for biofuel. The method can include heating a solid urea inclusion compound to a decomposition temperature, allowing the solid urea inclusion compound to decompose, heating again to a melting temperature, allowing the solid urea to melt, cooling to the decomposition temperature, and cooling again to a temperature below the decomposition temperature. Each heating, cooling, decomposing, and melting step can have its change in enthalpy and entropy recorded. A thermodynamic model can be calculated using the recorded changes in enthalpy and entropy. The thermodynamic model can predict a yield and composition of the solid urea inclusion compound and can be used to select a fatty acid methyl ester source using the predicted yield and composition.
G16C 60/00 - Science informatique des matériaux, c. à d. TIC spécialement adaptées à la recherche des propriétés physiques ou chimiques de matériaux ou de phénomènes associés à leur conception, synthèse, traitement, caractérisation ou utilisation
G06F 30/28 - Optimisation, vérification ou simulation de l’objet conçu utilisant la dynamique des fluides, p.ex. les équations de Navier-Stokes ou la dynamique des fluides numérique [DFN]
G16C 20/30 - Prévision des propriétés des composés, des compositions ou des mélanges chimiques
G16C 20/70 - Apprentissage automatique, exploration de données ou chimiométrie
2.
DUAL-MODE ELECTRICAL AND CHEMICAL PROPULSION SYSTEM FOR SMALL SPACECRAFT AND CUBESATS
A dual mode engine for propelling a spacecraft, including a combustion chamber having a flange end, an open nozzle end, and an enclosed chamber portion extending therebetween, a propellant tank in fluidic communication with the combustion chamber, an electronic controller, a power source operationally connected to the electronic controller, and a fluid flow motivator operationally connected to the electronic controller and connected in fluidic communication with the propellant tank. The engine further includes a chemical propulsion portion further including a propellant inlet port operationally connected to the combustion chamber and disposed adjacent the flange end, an ignition trigger electrode positioned in the combustion chamber adjacent the propellant inlet port and operationally connected to the electronic controller and operationally connected to the power source, wherein the propellant inlet port is fluidically connected to the propellant tank. The engine also includes an electric propulsion portion, further including at least two spaced electrodes for ionizing the propellant positioned in the combustion chamber adjacent the nozzle end, a plurality of attitude control thrusters operationally connected to the electronic controller and in fluidic communication with the propellant tank, and a plurality of respective valves, each respective valve fluidically connected between a respective attitude control thruster and the propellant tank, wherein the propellant inlet port is fluidically connected to the propellant tank.
Processes and systems for biologically producing hydrogen gas from organic waste, including food waste. Such a process includes biologically producing hydrogen gas from organic waste by anaerobic fermentation of the organic waste with at least one strain of yeast.
The invention generally relates to systems and methods for increasing reaction yield. In certain embodiments, the invention provides systems for increasing a yield of a chemical reaction that include a pneumatic sprayer configured to generate a liquid spray discharge from a solvent. The solvent includes a plurality of molecules, a portion of which react with each other within the liquid spray discharge to form a reaction product. The system also includes a collector positioned to receive the liquid spray discharge including the unreacted molecules and the reaction product. The system also includes a recirculation loop connected from the collector to the pneumatic sprayer in order to allow the unreacted molecules and the reaction product to be recycled through the pneumatic sprayer, thereby allowing a plurality of the unreacted molecules to react with each other as the unreacted molecules cycle again through the system.
B01J 4/00 - Dispositifs d'alimentation; Dispositifs de commande d'alimentation ou d'évacuation
B01J 14/00 - Procédés chimiques généraux faisant réagir des liquides avec des liquides; Appareillage spécialement adapté à cet effet
B01J 19/08 - Procédés utilisant l'application directe de l'énergie ondulatoire ou électrique, ou un rayonnement particulaire; Appareils à cet usage
B01J 19/26 - Réacteurs du type à injecteur, c. à d. dans lesquels la distribution des réactifs de départ dans le réacteur est effectuée par introduction ou injection au moyen d'injecteurs
B05B 5/03 - Appareillages pour délivrer le matériau, p.ex. pistolets de pulvérisation électrostatique caractérisés par l'utilisation de gaz
5.
Visualizing Causality in Mixed Reality for Manual Task Learning
A learning system is disclosed that leverages intention-driven causality to enhance skill learning. The learning system enables an author to easily develop mixed reality (MR) tutorial content for performing a task that advantageously captures causal relationships between steps and, thus, enables such causality to be conveyed to the novice user when learning how to perform the task. To this end, the learning system leverages a novel hierarchical representation of causality and intention alongside a systematic workflow suitable for designing skill learning content. By preserving and presenting causal information to the novice user, the user can better understand not only the steps required to perform a task, but also why each step is performed.
An assembly (decoupled grain sampler and moisture content reader) for measuring grain moisture and sharing the grain moisture information with a database, other framers, and merchants, including a grain receiving chamber, at least one plate capacitor operationally connected to the grain receiving chamber, a capacitance to digital converter (or similar device) operationally connected to the at least one plate capacitor, a microprocessor operationally connected to the oscillator, a user interface operationally connected to the microprocessor, a smartphone app in operational communication with the microprocessor, and a transceiver operationally connected to the microprocessor and the smartphone app.
G01N 27/22 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'impédance en recherchant la capacité
G01N 33/10 - Substances contenant de la fécule, p.ex. la pâte
7.
SYSTEM AND METHOD HAVING MOLECULAR REPRESENTATION FOR DEEP LEARNING OF MOLECULAR PROPERTY DESIGN AND PREDICTION
The present invention involves a method, a system, and software for a method of generating unique descriptors of intermolecular interactions by: 1) using quantum mechanical conceptual density functional theory (CDFT) calculations to generate measures of electron density from crystal structures; 2) generating the molecular surface by determining the contribution of electron in the crystal structure from individual molecules; and 3) creating a method called Manifold Embedding of the Molecular Surface (MEMS). MEMS embeds the CDFT calculated values onto the three-dimensional (3D) molecular surface which is then projected into two dimensions (2D) using a stochastic neighborhood embedding approach. From each atom location in the 2D space, radially and angularly distributed electrostatic potential and Fukui function values are taken as input for the neural network.
In an example in accordance with the present disclosure, a multi-tasking learning expression tracking system is described. The system includes a feature extractor to extract a feature representation from an image of a user. The system also includes a classification branch having a classification neural network and the feature extractor to, during training, predict expression classes for training images having different expressions. The system also includes a regression branch comprising a regression neural network and the feature extractor to, during training, predict action unit (AU) intensities for the training images and during deployment predict an AU intensity for the image of the user.
G06V 10/44 - Extraction de caractéristiques locales par analyse des parties du motif, p.ex. par détection d’arêtes, de contours, de boucles, d’angles, de barres ou d’intersections; Analyse de connectivité, p.ex. de composantes connectées
G06V 10/764 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant la classification, p.ex. des objets vidéo
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
G06V 40/16 - Visages humains, p.ex. parties du visage, croquis ou expressions
A toy with a ring-shaped body having multiple sections each forming a portion of the ring-shaped body and each having a tubular base portion. At least a first tab projects radially outward from the tubular base portion of a first section of the multiple sections. Surface features protrude from at least one of the first tab and the tubular base portion of at least one of the multiple sections. At least a first pressure sensor is embedded in the first tab and operates to activate a first electrical device in response to pressure applied to the first tab exceeding a pressure threshold. Activation of the first electrical device produces light, or sound, or vibrates.
The present disclosure generally relates to methods of treating hemolytic diseases such as sickle cell anemia using kinase inhibitors, for example, compounds that inhibit the spleen tyrosine kinase (SYK). In some embodiments a method is presented to prevent thrombosis in blood vessels of patients with a hemolytic disease comprising the step of: administrating to a patient having at least one hemolytic disease a therapeutically effective amount of at least one SYK inhibitor. In some embodiments the method includes repeatedly administering the SYK kinase inhibitor to a patient.
A method of covalently modifying tyrosines, tryptophans, and pyrrolated lysines in a protein comprising reacting the side chains of the amino acids with a cyclic imine Mannich electrophile appended to a ligand that binds to the protein; and a protein comprising a ligand binding site, which comprises one or more tyrosine, tryptophan or pyrrolated lysine residues, the side chains of which have been selectively covalently modified with a cyclic imine.
The electrocatalyst system that is configured to oxidize a methanol molecule using piezo-electrocatalysis includes a substrate and a piezoelectric semiconductor. The piezoelectric semiconductor is coupled to the substrate. The piezoelectric semiconductor includes a nanostructured semiconducting zinc oxide (ZnO) catalyst. The nanostructured semiconducting zinc oxide catalyst is characterized by a UV-ozone (UV-O3) treatment process. The electrocatalyst system may be provided in a methanol fuel cell.
H01M 8/1011 - PROCÉDÉS OU MOYENS POUR LA CONVERSION DIRECTE DE L'ÉNERGIE CHIMIQUE EN ÉNERGIE ÉLECTRIQUE, p.ex. BATTERIES Éléments à combustible; Leur fabrication Éléments à combustible avec électrolytes solides avec un des réactifs liquide, solide ou chargé en liquide Éléments à combustible à alcool direct, p.ex. éléments à combustible à méthanol direct
15.
IMAGE PROCESSING AND AUTHENTICATION OF UNCLONABLE FUNCTIONS
A method of authenticating an item is disclosed which includes applying light to an item, wherein the item includes a random distribution of fluorescent particles disposed thereon, capturing one or more images from the item, generating a cryptographic pattern from the one or more captured images by a host processing system, communicating the cryptographic pattern to a remote processing system having a plurality of cryptographic keys in a database each uniquely associated with a corresponding item, comparing the cryptographic pattern with the plurality of cryptographic keys in the database, and communicating a positive evaluation for authentication to the host processing system if a match is found between one of the plurality of cryptographic keys and the communicated cryptographic pattern.
H04L 9/32 - Dispositions pour les communications secrètes ou protégées; Protocoles réseaux de sécurité comprenant des moyens pour vérifier l'identité ou l'autorisation d'un utilisateur du système
16.
IMAGE ENHANCEMENT USING TEXTURE MATCHING GENERATIVE ADVERSARIAL NETWORKS
One or more systems, devices, computer program products and/or computer-implemented methods of use provided herein relate to image enhancement using a generative adversarial network (GAN). The computer-implemented system can comprise a memory that can store computer-executable components. The computer-implemented system can further comprise a processor that can execute the computer-executable components stored in the memory, wherein the computer-executable components can comprise a training component that can train a discriminator of the GAN to score a texture of a CT image, wherein the texture can be derived from a difference of two conditionally independent estimates produced by a generator of the GAN by respectively processing two independent noisy samples of images.
The invention generally relates to systems and methods for combined spectroscopy systems. In certain embodiments, laser-induced breakdown spectroscopy (LIBS) and Raman spectroscopy can be combined in a single, handheld device using a single spectrometer and two sources for simultaneous analysis using both methods.
G01J 3/30 - Mesure de l'intensité des raies spectrales directement sur le spectre lui-même
H01J 49/16 - Sources d'ions; Canons à ions utilisant une ionisation de surface, p.ex. émission thermo-ionique ou photo-électrique
A61B 1/05 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p.ex. endoscopes; Dispositions pour l'éclairage dans ces instruments combinés avec des dispositifs photographiques ou de télévision caractérisés par le fait que le capteur d'images, p.ex. l'appareil photographique, est placé dans la partie de l'extrémité distale
The construction system includes a composition that includes Portland cement, nano-TiO2, and slag cement. The composition may also include water. The composition is cured via a CO2 curing process to produce a self-cleaning photocatalytic composite with lower carbon footprint and may be more economically manufactured than known cement-based photocatalytic composites. The unveiled synergistic effect of using slag cement and applying a CO2 curing process may reduce the porosity of the material and reduce the penetration of the pollutants that will accumulate in the surface. Thus, pollutants will be more exposed to UV light and decompose the pollutants in a greater rate. The construction system is self-cleaning in that water, such as from rainfall, may effectively clean the cured composition to reset the sequestering capabilities for the construction system to continue to remove toxic gases for the atmosphere.
A method and system for hand-object interaction dataset collection is described herein, which is configured to support user-specified collection of hand-object interaction datasets. Such hand-object interaction datasets are useful, for example, for training 3D hand and object pose estimation model. The method and system adopt a sequential process of first recording hand and object pose labels by manipulating a virtual bounding box, rather than a physical object. Naturally, hand-object occlusions do not occur during the manipulation of the virtual bounding box, so these labels are provided with high accuracy. Subsequently, the images are separately captured of the hand-object interaction with the physical object. These images are paired with the previously recorded hand and object pose labels.
G06F 3/04815 - Interaction s’effectuant dans un environnement basé sur des métaphores ou des objets avec un affichage tridimensionnel, p.ex. modification du point de vue de l’utilisateur par rapport à l’environnement ou l’objet
G06F 3/01 - Dispositions d'entrée ou dispositions d'entrée et de sortie combinées pour l'interaction entre l'utilisateur et le calculateur
G06F 3/04842 - Sélection des objets affichés ou des éléments de texte affichés
G06F 3/04845 - Techniques d’interaction fondées sur les interfaces utilisateur graphiques [GUI] pour la commande de fonctions ou d’opérations spécifiques, p.ex. sélection ou transformation d’un objet, d’une image ou d’un élément de texte affiché, détermination d’une valeur de paramètre ou sélection d’une plage de valeurs pour la transformation d’images, p.ex. glissement, rotation, agrandissement ou changement de couleur
G06T 7/194 - Découpage; Détection de bords impliquant une segmentation premier plan-arrière-plan
G06T 7/73 - Détermination de la position ou de l'orientation des objets ou des caméras utilisant des procédés basés sur les caractéristiques
21.
EXCIPIENT-FREE LYOPHILIZATION OF POLYMER LUNG SURFACTANTS
The present disclosure relates to a protocol for the formulation and lyophilization of hydroxyl-terminated poly(ethylene glycol) (PEG) based block copolymer micelles without the use of excipients (cryo-protectants). The micelles are formulated using the equilibrium nanoprecipitation (ENP) method, which allows for control over the aggregation number of the micelles and thus the grafting density of the PEG micelle corona chains. By using the ENP method to produce micelles with high dimensionless PEG grafting densities (> about 7), the micelles are stabilized against aggregation during lyophilization due to the shielding of the micelle core domains by the dense PEG corona chains. By preventing aggregation during the lyophilization without using excipients, the original desired surface mechanical properties of the micelles are preserved after reconstitution. Therefore, the protocol described herein can be applied to effectively storing PEG-based block copolymer micelles without using excipients while still preserving their original surface mechanical properties.
B01D 61/00 - Procédés de séparation utilisant des membranes semi-perméables, p.ex. dialyse, osmose ou ultrafiltration; Appareils, accessoires ou opérations auxiliaires, spécialement adaptés à cet effet
A61K 47/60 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p.ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique macromoléculaire, p.ex. une molécule oligomérique, polymérique ou dendrimérique obtenu par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p.ex. polyurées ou polyuréthanes le composé organique macromoléculaire étant un oligomère, un polymère ou un dendrimère de polyoxyalkylène, p.ex. PEG, PPG, PEO ou polyglycérol
A safety vent assembly for a cylindrical battery may include a burst disk configured to open and at least partially define a vent in response to a thermal runaway of the battery. The safety vent assembly may further include a current collector and a positive terminal. A turbulence promoter may be defined on the current collector. Gas from inside the battery may pass through the turbulence promoter and the vent formed by the burst disk during thermal runaway.
H01M 50/213 - Bâtis, modules ou blocs de multiples batteries ou de multiples cellules caractérisés par leur forme adaptés aux cellules ayant une section transversale courbée, p.ex. ronde ou elliptique
H01M 50/30 - Aménagements pour faciliter l’échappement des gaz
H01M 50/358 - Passages externes d’évacuation des gaz sur le couvercle ou sur le boîtier de batterie
H01M 50/559 - Bornes adaptées aux cellules ayant une section transversale courbée, p.ex. ronde ou elliptique
23.
AUTHORING SYSTEMS AND METHODS FOR ENABLING BIDIRECTIONAL BINDING OF AUGMENTED REALITY WITH TOYS IN REAL-TIME
An augmented reality (AR) interaction authoring system is described. The AR interaction authoring system is configured to support the real-time creation of AR applications to support AR-enhanced toys. The design of the AR interaction authoring system enables bidirectional interactions between the physical-virtual space of toys and AR. The AR interaction authoring system allows intuitive authoring of AR animations and toys actuations through programming by demonstration, while referring to the physical toy for a contextual reference. Using a visual programming interface, users can create bidirectional interactions by utilizing users' input on toys to trigger AR animations and vice versa. A plug-and-play IoT toolkit is also disclosed that includes hardware to actuate common toys. In this way, users can effortlessly integrate toys into the virtual world in an impromptu design process, without lengthy electronic prototyping.
G06T 19/00 - Transformation de modèles ou d'images tridimensionnels [3D] pour infographie
A63F 13/577 - Simulations de propriétés, de comportement ou de déplacement d’objets dans le jeu, p.ex. calcul de l’effort supporté par un pneu dans un jeu de course automobile utilisant la détermination de la zone de contact entre les personnages ou les objets du jeu, p.ex. pour éviter une collision entre des voitures de course virtuelles
A63F 13/63 - Création ou modification du contenu du jeu avant ou pendant l’exécution du programme de jeu, p.ex. au moyen d’outils spécialement adaptés au développement du jeu ou d’un éditeur de niveau intégré au jeu par le joueur, p.ex. avec un éditeur de niveaux
A63F 13/655 - Création ou modification du contenu du jeu avant ou pendant l’exécution du programme de jeu, p.ex. au moyen d’outils spécialement adaptés au développement du jeu ou d’un éditeur de niveau intégré au jeu automatiquement par des dispositifs ou des serveurs de jeu, à partir de données provenant du monde réel, p.ex. les mesures en direct dans les compétitions de course réelles par importation de photos, p.ex. du joueur
G06F 3/0346 - Dispositifs de pointage déplacés ou positionnés par l'utilisateur; Leurs accessoires avec détection de l’orientation ou du mouvement libre du dispositif dans un espace en trois dimensions [3D], p.ex. souris 3D, dispositifs de pointage à six degrés de liberté [6-DOF] utilisant des capteurs gyroscopiques, accéléromètres ou d’inclinaiso
G06F 3/04815 - Interaction s’effectuant dans un environnement basé sur des métaphores ou des objets avec un affichage tridimensionnel, p.ex. modification du point de vue de l’utilisateur par rapport à l’environnement ou l’objet
24.
OPTICAL PHASED ARRAY GRATINGS BASED ON EXTREME SKIN-DEPTH METAMATERIAL WAVEGUIDES
An optical waveguide may include a core that is substantially transparent at an operating wavelength. The core may extend along a longitudinal direction. The optical waveguide may further include a cladding positioned on either side of the core. The cladding may include a plurality of layers, and each layer may extend along the longitudinal direction. At least one of the layers may include a plurality of elongated rods of a high index semiconductor. A gap may be defined between respective ends of the rods.
G02F 1/295 - Dispositifs ou dispositions pour la commande de l'intensité, de la couleur, de la phase, de la polarisation ou de la direction de la lumière arrivant d'une source lumineuse indépendante, p.ex. commutation, ouverture de porte ou modulation; Optique non linéaire pour la commande de la position ou de la direction des rayons lumineux, c. à d. déflexion dans une structure de guide d'ondes optique
G02B 6/124 - Lentilles géodésiques ou réseaux intégrés
25.
MECHANICALLY ROBUST AND SELF-HEALABLE PEROVSKITE SOLAR CELLS
A perovskite-polymer composite comprising a perovskite and a polymer, wherein the polymer has a structural unit comprising a thiourea (—HN(C═S)NH—) fragment and a (—R1—O—R2—) fragment, wherein R1 and R2 are each independently a C1-C6 alkyl or a cycloalkyl linker; a mechanically robust and self-healable solar cell comprising same; and a method of making same.
A system and method for multi-media instruction authoring is disclosed. The multi-media instruction authoring system and method provide a unified and efficient system that supports the simultaneous creation of instructional media in AR, VR, and video-based media formats by subject matter experts. The multi-media instruction authoring system and method require only a single demonstration of the task by the subject matter expert and does not require any technical expertise of the subject matter expert. The multi-media instruction authoring system and method incorporate a 3D editing interface for free hand, in-headset interaction to create 2D videos from 3D recordings, by exploring novel virtual camera interactions.
NATIONAL UNIVERSITY OF IRELAND, MAYNOOTH (Irlande)
Inventeur(s)
Siskind, Jeffrey Mark
Pearlmutter, Barak Avrum
Abrégé
A system and method which allows the basic checkpoint-reverse-mode AD strategy (of recursively decomposing the computation to reduce storage requirements of reverse-mode AD) to be applied to arbitrary programs: not just programs consisting of loops, but programs with arbitrarily complex control flow. The method comprises (a) transforming the program into a formalism that allows convenient manipulation by formal tools, and (b) introducing a set of operators to allow computations to be decomposed by running them for a given period of time then pausing them, while treating the paused program as a value subject to manipulation.
G06F 9/30 - Dispositions pour exécuter des instructions machines, p.ex. décodage d'instructions
G06F 7/544 - Méthodes ou dispositions pour effectuer des calculs en utilisant exclusivement une représentation numérique codée, p.ex. en utilisant une représentation binaire, ternaire, décimale utilisant des dispositifs non spécifiés pour l'évaluation de fonctions par calcul
G06F 7/60 - Méthodes ou dispositions pour effectuer des calculs en utilisant une représentation numérique non codée, c. à d. une représentation de nombres sans base; Dispositifs de calcul utilisant une combinaison de représentations de nombres codées et non codées
G06F 11/36 - Prévention d'erreurs en effectuant des tests ou par débogage de logiciel
G06F 17/13 - Opérations mathématiques complexes pour la résolution d'équations d'équations différentielles
G06F 17/17 - Opérations mathématiques complexes Évaluation de fonctions par des procédés d'approximation, p.ex. par interpolation ou extrapolation, par lissage ou par le procédé des moindres carrés
G06N 5/01 - Techniques de recherche dynamique; Heuristiques; Arbres dynamiques; Séparation et évaluation
28.
OPTICAL SENSITIZER DEVICE AND METHOD FOR LOW-ENERGY LASER IGNITION OF PROPELLANTS
An igniter system and method for igniting a propellant by an optical energy source. The igniter system including an igniter composite and a propellant. The igniter composite including a reactive component and a fluoropolymer. The propellant is coupled to the igniter composite. The igniter composite has a composition including nano-aluminum at ideal stoichiometry in polyvinylidene fluoride. The igniter composite is configured to achieve a sustained ignition from a wavelength emitted from the optical energy source. The wavelength is between around 250 nanometers to around 1100 nanometers.
F02P 23/04 - Autres moyens physiques d'allumage, p.ex. par laser
F02K 9/95 - Moteurs-fusées, c. à d. ensembles fonctionnels portant à la fois le combustible et son oxydant; Leur commande caractérisés par des moyens ou des aménagements de démarrage ou d'allumage
29.
TREATMENT OF INFECTIONS AND BIOFILM FORMATION USING A CELLULOSE SYNTHASE INHIBITOR
In one embodiment, the present application relates to methods and materials for weed control of a field of a crop plant using a cellulose biosynthesis inhibitor selected from the group consisting of ES20 and ES20-1 to ES20-9 of FIG. 1A. In another embodiment, the present disclosure relates to a method for treatment or prevention of an infection through inhibition of biofilm formation of microorganisms comprising the step of applying a therapeutic effective amount of a cellulose biosynthesis inhibitor selected from the group consisting of ES20 and ES20-1˜ES20-9 of FIG. 1A, or a salt thereof, in combination with one or more other commonly used antibiotics. A composition matter comprising said compounds and methods of use are within the scope of the present invention.
A61K 31/44 - Pyridines non condensées; Leurs dérivés hydrogénés
A01N 47/30 - Dérivés contenant le groupe N—CO—N—aryle ou N—CS—N—aryle
A01N 47/34 - Urées ou thiourées contenant les groupes N—CO—N ou N—CS—N contenant les groupes p.ex. biuret; Leurs thio-analogues; Produits de condensation urée-aldéhyde
A01N 47/36 - Urées ou thiourées contenant les groupes N—CO—N ou N—CS—N contenant le groupe N—CO—N lié directement à au moins un hétérocycle; Leurs thio-analogues
A61K 31/17 - Amides, p.ex. acides hydroxamiques ayant le groupe N-C(O)-N ou N-C(S)-N, p.ex. urée, thiourée, carmustine
A61K 31/381 - Composés hétérocycliques ayant le soufre comme hétéro-atome d'un cycle ayant des cycles à cinq chaînons
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p.ex. composés antiphlogistiques et pour le cœur
A61L 2/00 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contact; Accessoires à cet effet
A61L 2/16 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contact; Accessoires à cet effet utilisant des substances chimiques
A shape-morphing fin includes a fixed portion, a multistable portion, a coupling portion, and a vibration source. The multistable portion functions as a negative stiffness element. The multistable portion is selectively movable between a first position and a second position. The movement between first position and the second position is configured to remove the ice formation from the structure. The coupling portion couples the fixed portion to the multistable portion. The vibration source is configured to produce a resonant vibration to engage the movement of the multistable portion from the first position to the second position.
In examples, an electronic device is provided. The electronic device includes a processor to receive an input image from an image sensor. The processor is also to scale a size of the input image to a programmed size. The processor is also to encode the scaled input image to provide a feature map having a fractional size of the scaled input image. The processor is also to process the feature map according to lite reduced atrous spatial pyramid pooling (LR-ASPP) to provide a LR-ASPP result. The processor is also to decode the LR-ASPP result to provide an image segmentation result.
G06T 7/33 - Détermination des paramètres de transformation pour l'alignement des images, c. à d. recalage des images utilisant des procédés basés sur les caractéristiques
A temporally multi-staged assembly for reverse osmotically desalinating water is disclosed. Temporally multi-staged batch CFRO is realized by connecting each side of an RO membrane to one or more recirculation tanks. The side of the membrane that loses water is called the concentrate side while the other side gaining water is called the diluate side. In this embodiment a pressure exchanger design is used and hence the recirculation tanks are maintained at atmospheric pressure. Each stage operates in the same way as single-stage batch CFRO starting with the same concentrate and diluate salinity. The difference lies in the way the diluate is processed in each stage. For single-stage batch CFRO that dewaters seawater RO brine, the diluate produced is at seawater salinity and is used to increase the recover of the combined RO-CFRO s stem.
The present disclosure teaches a method of treating a patient in need of therapeutic intervention with bioactive cyclic peptide molecules which are useful as antimicrobials, anticancer agents, antiparasitic, immunosuppressants, and others.
C07D 409/12 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
C07D 409/14 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
35.
METHOD AND SYSTEM UTILIZING PULSE VOLTAMMETRY FOR TESTING BATTERY
A state of battery testing system is disclosed which includes a charger, a load to be coupled across the battery's positive and negative terminals, a processer adapted to apply a predetermined voltage pulse across the battery's positive and negative terminals, apply the load to the battery, measure and log current through the load as Iexp, and establish a model based on establishing an initial estimation of state of the battery (θ0), and establishing a modeled state of battery (θi) based on a plurality of internal parameters of the battery. The model is adapted to output a model current through the load, inputting θ0 and the plurality of internal parameters of the model to thereby generate Imodel, generate an objective function (f) based on a comparison of Imodel and Iexp, and iteratively optimize θi, and output θoptimal based on the iterations.
G01R 31/36 - Dispositions pour le test, la mesure ou la surveillance de l’état électrique d’accumulateurs ou de batteries, p.ex. de la capacité ou de l’état de charge
G01R 31/367 - Logiciels à cet effet, p.ex. pour le test des batteries en utilisant une modélisation ou des tables de correspondance
G01R 31/3842 - Dispositions pour la surveillance de variables des batteries ou des accumulateurs, p.ex. état de charge combinant des mesures de tension et de courant
G01R 31/392 - Détermination du vieillissement ou de la dégradation de la batterie, p.ex. état de santé
36.
CERAMIC SCINTILLATING MATERIALS AND METHODS OF FABRICATION THEREOF
A method of fabricating a material is described. The method includes preparing a powder mixture including yttrium aluminum garnet doped with a fissionable isotope, grinding the powder mixture to form a first milled powder, drying the first milled powder, calcinating the first milled powder to form a calcinated powder, grinding the calcinated powder to form a second milled powder, drying the second milled powder, shaping the second milled powder to form a plurality of shaped material portions, and sintering the plurality of shaped material portions.
B22F 3/16 - Compactage et frittage par des opérations successives ou répétées
B22F 1/142 - Traitement thermique ou thermomécanique
B22F 9/04 - Fabrication des poudres métalliques ou de leurs suspensions; Appareils ou dispositifs spécialement adaptés à cet effet par des procédés physiques à partir d'un matériau solide, p.ex. par broyage, meulage ou écrasement à la meule
A woven structure includes thermoelectric ribbons interwoven with thread. Each thermoelectric ribbon includes a matrix of thermoelectric elements, the matrix having an insulating substrate that supports plural rows of thermoelectric elements, a plurality of conductive elements, and two terminals. The conductive elements form a series connection of the thermoelectric elements between the two terminals. A set of first conductive elements have a first temperature and a set of second conductive contacts have a second temperature lower than the first temperature when a first current flows in a first direction between the first matrix terminal and the second matrix terminal. The matrix is configured to form spaced-apart alternating stacks of the first conductive contacts and second conductive contacts. Each length of the yard or thread is interwoven such that it passes alternately under stacks of first conductive contacts and over stacks of second conductive contacts.
H10N 10/17 - Dispositifs thermoélectriques comportant une jonction de matériaux différents, c. à d. dispositifs présentant l'effet Seebeck ou l'effet Peltier fonctionnant exclusivement par les effets Peltier ou Seebeck caractérisés par la structure ou la configuration de la cellule ou du thermocouple constituant le dispositif
D03D 1/00 - Tissus conçus pour faire des articles particuliers
D03D 15/533 - Tissus caractérisés par la matière, la structure ou les propriétés des fibres, des filaments, des filés, des fils ou des autres éléments utilisés en chaîne ou en trame caractérisés par les propriétés des filés ou des fils électriquement conducteurs
38.
Simultaneous Multi-Slice MRSI Using Density Weighted Concentric Ring Acquisition
A method of performing magnetic resonance spectroscopic imaging (MRSI) includes transmitting a multi-slice excitation pulse through tissue, the multi-slice excitation pulse configured to generate multi-slice MRSI signals. The method also includes performing density weighted concentric ring acquisition on the multi-slice MRSI signals. The method further includes receiving the generated multi-slice MRSI signals in a plurality of sensors disposed in various locations around the tissue. Imaging data is reconstructed based on the acquired imaging signals. A representation of the data is displayed.
G01R 33/483 - Systèmes d'imagerie RMN avec sélection de signaux ou de spectres de régions particulières du volume, p.ex. spectroscopie in vivo
A61B 5/055 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiques; Mesure utilisant des micro-ondes ou des ondes radio faisant intervenir la résonance magnétique nucléaire [RMN] ou électronique [RME], p.ex. formation d'images par résonance magnétique
G01R 33/485 - Systèmes d'imagerie RMN avec sélection de signaux ou de spectres de régions particulières du volume, p.ex. spectroscopie in vivo basés sur l'information de déplacement chimique
The solvated metal particle-coating system includes a metal additive and a polar outer-sphere electron transferring solvent. The metal additive is solvated in the polar outer-sphere electron transferring solvent. The polar outer-sphere electron transferring solvent may include liquid ammonia, methylamine, and/or hexamethylphosphoramide. The metal additive may include an alkali metal and/or an alkaline earth metal. The solvated metal additive within the polar outer-sphere electron transferring solvent may be used to coat a metal particle and/or a metalloid particle as a layer. As the polar outer-sphere electron transferring solvent evaporates, the solvated metal additive is coupled to the metal particle and/or the metalloid particle.
A system may provide an eco-feedback and gaming platform for home energy management. The system may generate daily energy scores for a plurality of households. The system may prepare a community energy conservation game in which community conservation goals and participation thresholds are generated. The system may execute the game by receiving time series date from each of the households and rewards the households for participating in achieving the community goal.
G06Q 30/0207 - Remises ou incitations, p.ex. coupons ou rabais
A63F 13/798 - Aspects de sécurité ou de gestion du jeu incluant des données sur les joueurs, p.ex. leurs identités, leurs comptes, leurs préférences ou leurs historiques de jeu pour évaluer les compétences ou pour classer les joueurs, p.ex. pour créer un tableau d’honneur des joueurs
A63F 13/80 - Adaptations particulières pour exécuter un genre ou un mode spécifique de jeu
G06Q 50/06 - Fourniture d'électricité, de gaz ou d'eau
41.
METHODS, ALGORITHMS AND SYSTEMS FOR SUB-NANOSECOND DIGITAL SIGNAL PROCESSING OF PHOTOMULTIPLIER TUBE RESPONSE TO ENABLE MULTI-PHOTON COUNTING IN RAMAN SPECTROSCOPY
A computer-implemented method of determining the number of photons contributing to an output of a photonic sensor, including receiving an electrical signal from the photonic sensor proportional to a number of photons the photonic sensor detects at its input as a function of time, wherein the photonic sensor is calibrated such that a response of the photonic sensor to a single photon detected is in a waveform comprising an amplitude and time, wherein the product amplitude X time is statistically bounded, determining a probabilistic boundary between one or more of electrical, optical, and thermal sources of noise of the sensor, acquiring each response wave form from the sensor through analog-to-digital conversion with a resolution in amplitude and time corresponding to accuracy required in quantifying the response, storing each acquired response, individually, in real-time, or in buffered packets in digital form, determining the number of photons for a specific time resolved acquisition, and effecting a summation of the count of photon arrivals obtained based on amplitude evaluation from each specific time resolved acquisition, for all time resolved acquisitions performed in a given observation period, yielding the number of photon arrivals associated with the amplitude evaluation.
The present invention relates to a method of treatment for chronic pain, opioid dependence, alcohol use disorder or autism using a class of pyrimidinone compounds, an adenylyl cyclase 1 (AC1) inhibitor. The invention described herein also pertains to pharmaceutical compositions and methods for treating diseases in mammals using those compounds disclosed herein.
C07D 403/04 - Composés hétérocycliques contenant plusieurs hétérocycles, comportant des atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une liaison directe de chaînon cyclique à chaînon cyclique
A61P 25/36 - Médicaments pour le traitement des troubles du système nerveux des états d'abus ou de dépendance aux opiacés
C07D 405/14 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
C07D 409/14 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
43.
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LOWE SYNDROME
A combination of active agents for the treatment of Lowe Syndrome (LS) comprising a RhoA inhibitor and a mTOR inhibitor; a pharmaceutical composition comprising the combination and a pharmaceutically acceptable carrier; a combination of pharmaceutical compositions in which one composition comprises a RhoA inhibitor and the other composition comprises a mTOR inhibitor; and a method of treating a patient for LS.
A61K 31/436 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p.ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle condensés en ortho ou en péri avec des systèmes hétérocycliques le système hétérocyclique contenant un cycle à six chaînons ayant l'oxygène comme hétéro-atome du cycle, p.ex. rapamycine
A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
44.
APPARATUSES AND METHODS FOR CREATING WETTING CONTROLLING MICROFEATURES
Apparatuses and methods for creating phobic and philic surfaces (for example, superphobic and superphilic surfaces) are disclosed. Embodiments include methods for determining a heat treatment technique that increases the likelihood that a uniformly etched surface with minimal pitting will be formed when the surface of a material is subject to etching. Additional embodiments include evaluating the PRE number of the material, performing an anodic polarization sweep of the material, evaluating the polarization curve (current vs. potential) for the material, performing different etching protocols depending on the range of values the PRE number of the material belongs, and/or pulsing the current applied to the material during the etching process. Additional embodiments include apparatuses and methods for predictably etching a surface (such as a surface of a metal alloy) of a material, which can include etching interior portions of a hollow work piece.
The invention generally relates to electrophoretic mass spectrometry probes and systems and methods of uses thereof. In certain aspects, the invention provides a mass spectrometry probe having a hollow body with a distal tip, an electrically conductive hollow conduit, and an electrode. The electrically conductive hollow conduit may be operably coupled to a reservoir and a power source, and the electrically conductive hollow conduit may be configured to transport a liquid sample into the hollow body and polarize the liquid sample as it flows through the electrically conductive hollow conduit and into in the hollow body. The electrode and the electrically conductive hollow conduit are disposed within the hollow body (e.g., at different heights within the hollow body).
H01J 49/04 - Dispositions pour introduire ou extraire les échantillons devant être analysés, p.ex. fermetures étanches au vide; Dispositions pour le réglage externe des composants électronoptiques ou ionoptiques
A61B 5/029 - Mesure du débit de sang à la sortie du cœur, p.ex. volume éjecté par minute
A61B 5/05 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiques; Mesure utilisant des micro-ondes ou des ondes radio
47.
IN-SITU CREEP CAPSULE FOR A NUCLEAR REACTOR AND METHODS OF USE
An in-situ creep capsule for a nuclear reactor, and methods of using. The capsule has a modular design which allows it to be used to test multiple different types and sizes of specimens and to be adapted for use in various different nuclear reactor configurations. The capsule may include an integrated heat exchanger to cool measuring instrumentation, which allows the capsule to be used for gathering data in-situ in next generation reactors with higher temperatures while the reactor is running.
G21C 17/10 - Combinaison structurelle de l'élément combustible, de la barre de commande, du cœur du réacteur, ou de la structure du modérateur avec des instruments sensibles, p.ex. pour la mesure de la radioactivité, des contraintes
G01D 5/22 - Moyens mécaniques pour le transfert de la grandeur de sortie d'un organe sensible; Moyens pour convertir la grandeur de sortie d'un organe sensible en une autre variable, lorsque la forme ou la nature de l'organe sensible n'imposent pas un moyen de conversion déterminé; Transducteurs non spécialement adaptés à une variable particulière utilisant des moyens électriques ou magnétiques influençant la valeur d'un courant ou d'une tension en faisant varier l'inductance, p.ex. une armature mobile influençant deux bobines par une action différentielle
The invention generally relates to methods for employing mass spectrometry techniques to sequence and analyze biological molecules, such as glycan. In certain aspects, the invention provides methods for sequencing a biological molecule that involve conducting two-dimensional tandem mass spectrometry (2D MS/MS) and in-source collision-induced dissociation (IS-CID) on an ionized biological molecule to generate and analyze a plurality of precursor-product ion pairs of the biological molecule to thereby determine an interrelationship of the plurality of precursor-product ion pairs and sequence the biological molecule.
G01N 33/68 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des protéines, peptides ou amino-acides
H01J 49/00 - Spectromètres pour particules ou tubes séparateurs de particules
The combustion system includes a metal additive and a polar outer-sphere electron transferring solvent. The metal additive is solvated in the polar outer-sphere electron transferring solvent. The polar outer-sphere electron transferring solvent may include liquid ammonia, methylamine, and/or hexamethylphosphoramide. The metal additive may include an alkali metal and/or an alkaline earth metal. For instance, the metal additive may include lithium, sodium, aluminum, zirconium, titanium, yttrium, hafnium, and/or magnesium.
C06B 43/00 - Compositions caractérisées par des constituants explosifs ou thermiques non prévus en
C06B 33/00 - Compositions contenant des particules de métal, alliage, bore, silicium, sélénium ou tellure avec au moins un matériau fournissant de l'oxygène, qui est soit un oxyde métallique, soit un sel, organique ou inorganique, susceptible de donner un oxyde m
50.
SUPRAMOLECULAR ASSEMBLIES, COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME
Supramolecular assemblies, compositions thereof, and methods for preparing and use the same are provided. The supramolecular assemblies comprise a trimeric variant of a GCN4 peptide capable of self-assembly and incorporating one or more guest molecules in a functional 3D native structure.
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c. à d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
A61K 47/52 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p.ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé inorganique, p.ex. un ion inorganique complexé avec l’ingrédient actif
C07K 14/395 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de champignons provenant de levures provenant de Saccharomyces
51.
ETHER-BASED ELECTROLYTES FOR LITHIUM METAL BATTERIES, LITHIUM METAL BATTERIES, AND METHODS OF USE
Ether-based electrolytes for lithium metal batteries, lithium metal batteries, and methods of their use. Such an ether-based electrolyte includes a highly-nonpolar, nonfluorinated dipropyl ether (DPE) solvent that enhances the oxidation stability of a lithium metal battery. Such a lithium metal battery includes the ether-based electrolyte electrochemically coupling an anode and cathode of the battery.
H01M 10/0569 - Matériaux liquides caracterisés par les solvants
H01M 4/38 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'éléments simples ou d'alliages
H01M 4/505 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de manganèse d'oxydes ou d'hydroxydes mixtes contenant du manganèse pour insérer ou intercaler des métaux légers, p.ex. LiMn2O4 ou LiMn2OxFy
H01M 4/525 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques de nickel, de cobalt ou de fer d'oxydes ou d'hydroxydes mixtes contenant du fer, du cobalt ou du nickel pour insérer ou intercaler des métaux légers, p.ex. LiNiO2, LiCoO2 ou LiCoOxFy
SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE) (USA)
Inventeur(s)
Low, Philip Stewart
Chu, Haiyan
Lu, Yingjuan June
Leamon, Christopher Paul
Wheeler, Ii, Leroy W.
Jensen, Michael C.
Matthaei, James
Abrégé
The present disclosure relates to methods of treating a patient with a cancer by administering to the patient a composition comprising CAR T cells wherein the CAR T cells comprise a CAR and the CAR comprises an E2 anti-fluorescein antibody fragment, and administering to the patient a small molecule linked to a targeting moiety by a linker. The disclosure also relates to compositions for use in such methods.
For each avatar, testing images are rendered for different facial expressions that each have ground truth facial action units. An instance of a machine learning model is applied to the testing images to generate predicted facial action units for each testing image. A predictive performance of the instance is calculated for each avatar based on the predicted and ground truth facial action units for the testing images of the avatar. A first set of features common to the avatars for which the predictive performance was better than a first threshold, and a second set of features common to the avatars for which the predictive performance was worse than a second threshold, are identified. The features present only in the second set are identified, as difference features. New avatars having the difference features are generated.
G06V 10/776 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant l’intégration et la réduction de données, p.ex. analyse en composantes principales [PCA] ou analyse en composantes indépendantes [ ICA] ou cartes auto-organisatrices [SOM]; Séparation aveugle de source Évaluation des performances
G06V 40/16 - Visages humains, p.ex. parties du visage, croquis ou expressions
G06V 10/774 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant l’intégration et la réduction de données, p.ex. analyse en composantes principales [PCA] ou analyse en composantes indépendantes [ ICA] ou cartes auto-organisatrices [SOM]; Séparation aveugle de source méthodes de Bootstrap, p.ex. "bagging” ou “boosting”
G06V 10/94 - Architectures logicielles ou matérielles spécialement adaptées à la compréhension d’images ou de vidéos
G06V 20/20 - RECONNAISSANCE OU COMPRÉHENSION D’IMAGES OU DE VIDÉOS Éléments spécifiques à la scène dans les scènes de réalité augmentée
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
G06V 10/44 - Extraction de caractéristiques locales par analyse des parties du motif, p.ex. par détection d’arêtes, de contours, de boucles, d’angles, de barres ou d’intersections; Analyse de connectivité, p.ex. de composantes connectées
The invention generally relates to systems and methods that employ a novel wall shear stress (WSS) estimation method for 4D flow MRI. In certain embodiments, the invention provides systems and methods for determining Wall Shear Stress (WSS) with 4D flow Magnetic Resonance Imaging (MRI), that involve receiving 4D MRI flow data; calculating a velocity gradient (and optionally calculating the pressure field) from the 4D MRI flow data; correcting the velocity gradient (such as by using a spatial gradient of the pressure field to correct the velocity gradient), thereby producing a corrected velocity gradient; and determining a WSS from the corrected velocity gradient.
A61B 5/055 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiques; Mesure utilisant des micro-ondes ou des ondes radio faisant intervenir la résonance magnétique nucléaire [RMN] ou électronique [RME], p.ex. formation d'images par résonance magnétique
G01R 33/563 - Amélioration ou correction de l'image, p.ex. par des techniques de soustraction ou d'établissement de moyenne de matériaux en mouvement, p.ex. angiographie à écoulement contrasté
55.
LIGHT PIPE MICROSCOPE FOR LARGE-SCALE DYNAMIC IMAGING
An apparatus for large-scale dynamic imaging of a sample is described. The apparatus includes an optical detector, a light guide, a dichroic beam splitter, and a light source. The light guide includes a first portion and a second portion. The second defines a tapered shape such that a first diameter defined by a distal end of the second portion is smaller than a second diameter defined by a proximal end of the second portion. The dichroic beam splitter is positioned between the first portion and the second portion of the light guide. The light source is configured to direct a light beam through an external surface of the dichroic beam splitter. The dichroic beam splitter is configured to direct the light beam toward the second open end of the light guide and transfer the return emitted signal through the light guide to the optical detector.
Systems and methods capable for use in the development of high-speed, shape-transitioning, inward-turning inlets for air-breathing hypersonic vehicles, and inlets formed thereby. The systems and methods preferably provide for designing high-speed inlets for air-breathing hypersonic vehicles, wherein unique solutions are defined in each osculating plane of the inlet. Such systems and methods optionally provide an optimization process for tuning the post throat-shock Mach number of the inlet, and/or designs a shock-capture surface using a parallel-streamlines methodology, and/or a double cowl-lip geometry to allow flow to spill overboard.
F02K 7/10 - Ensembles fonctionnels dans lesquels le fluide de travail est utilisé uniquement sous forme de jet, c. à d. ensembles ne comportant ni turbine ni autre moteur entraînant un compresseur ou une soufflante carénée; Leur commande caractérisés par une compression dans un diffuseur, c. à d. tubulures aéro-thermodynamiques ou statoréacteurs
57.
ASSAYS, KITS AND METHODS FOR DETECTION OF BOVINE RESPIRATORY DISEASE COMPLEX-ASSOCIATED PATHOGENS
Assays, kits, and methods that target and/or detect the presence of bovine respiratory complex (BRD)-associated pathogens in a sample. These assays, kits and methods can be portable and capable of providing fast (within 45 minutes) and accurate (at least 96%) results in the field, eliminating the need for a laboratory and other complex equipment.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p.ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
58.
METHODS OF PRODUCING CARBON/CARBON COMPOSITE PREFORMS AND CARBON/CARBON COMPOSITES FORMED THEREFROM
Methods of manufacturing carbon/carbon preforms and carbon/carbon composites formed therefrom. Such a method includes extruding a polymer composite material using an extrusion deposition additive manufacturing process to form a preform, and heating the preform via pyrolysis to form the carbon/carbon composite.
Provided is a method of reducing a number of viable microbes, including contacting microbes with an antibiotic compound and applying pulses of electricity having a duration of between about 50 nanoseconds and about 900 nanoseconds. The pulses of electricity may have an intensity between about 20 kV/cm and about 40 kV/cm. The pulses of electricity may be applied at a frequency of between about 0.1 Hz and about 10 Hz. The microbes may be a gram-negative or a gram-positive strain of bacteria and the antibiotic may be applied at a concentration for a duration, wherein applying the antibiotic to the strain at the concentration for the duration does not reduce a viable number of bacteria of the strain as much, or at all, when the pulses of electricity are not also applied.
A61K 41/00 - Préparations médicinales obtenues par traitement de substances par énergie ondulatoire ou par rayonnement corpusculaire
A61K 31/341 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p.ex. fungichromine ayant des cycles à cinq chaînons avec un oxygène comme seul hétéro-atome d'un cycle, p.ex. isosorbide non condensés avec un autre cycle, p.ex. ranitidine, furosémide, bufétolol, muscarine
A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p.ex. rifampine, thiothixène
A61K 31/5377 - 1,4-Oxazines, p.ex. morpholine non condensées et contenant d'autres hétérocycles, p.ex. timolol
A61K 31/575 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrène; Leurs dérivés, p.ex. stéroïdes substitués en position 17 bêta par une chaîne d'au moins trois atomes de carbone, p.ex. cholane, cholestane, ergostérol, sitostérol
A61K 31/702 - Oligosaccharides, c. à. d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p.ex. leucoglucosane, hespéridine, érythromycine, nystatine
A61K 38/14 - Peptides contenant des radicaux saccharide; Leurs dérivés
A61N 1/32 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents
C12N 13/00 - Traitement de micro-organismes ou d'enzymes par énergie électrique ou ondulatoire, p.ex. par magnétisme, par des ondes sonores
In some examples, a computing device can include a processor resource and a non-transitory memory resource storing machine-readable instructions stored thereon that, when executed, cause the processor resource to: identify a plurality of regions within a captured document, determine a quantity of vertical transitions and horizontal transitions within the plurality of regions, and select an output resolution for the plurality of regions based on the quantity of vertical transitions and horizontal transitions within the plurality of regions.
H04N 1/00 - Balayage, transmission ou reproduction de documents ou similaires, p.ex. transmission de fac-similés; Leurs détails
G06V 10/44 - Extraction de caractéristiques locales par analyse des parties du motif, p.ex. par détection d’arêtes, de contours, de boucles, d’angles, de barres ou d’intersections; Analyse de connectivité, p.ex. de composantes connectées
G06V 10/764 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant la classification, p.ex. des objets vidéo
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
G06V 30/414 - Extraction de la structure géométrique, p.ex. arborescence; Découpage en blocs, p.ex. boîtes englobantes pour les éléments graphiques ou textuels
An example device is described for facilitating polygon localization. In various aspects, the device can comprise a processor. In various instances, the device can comprise a non-transitory machine-readable memory that can store machine-readable instructions. In various cases, the processor can execute the machine-readable instructions, which can cause the processor to localize a polygon depicted in an image, based on execution of a deep learning pipeline. In various aspects, the deep learning pipeline can comprise a circular-softmax block.
G06V 10/75 - Appariement de motifs d’image ou de vidéo; Mesures de proximité dans les espaces de caractéristiques utilisant l’analyse de contexte; Sélection des dictionnaires
G06V 10/94 - Architectures logicielles ou matérielles spécialement adaptées à la compréhension d’images ou de vidéos
62.
SYNERGISTIC EFFECT OF ISOXABEN AND CELLULOSIN AS AN HERBICIDE
The present application relates to a method of weed control for a crop field using a synergistic effect of two herbicides cellulosin and isoxaben. A composition matter together with said method comprising cellulosin and isoxaben is within the scope of the present invention.
A01N 43/80 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés hétérocycliques comportant des cycles avec des atomes d'azote et des atomes d'oxygène ou de soufre, comme hétéro-atomes du cycle des cycles à cinq chaînons avec un atome d'azote et soit un atome d'oxygène, soit un atome de soufre, en positions 1,2
A01N 47/34 - Urées ou thiourées contenant les groupes N—CO—N ou N—CS—N contenant les groupes p.ex. biuret; Leurs thio-analogues; Produits de condensation urée-aldéhyde
63.
DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
The present application generally relates to a method to treat a patient with a bacterial infection caused by Clostridium difficile. Particularly the method compromises the step of administering a therapeutically effective amount of diiodohydroxyquinoline, with or without one or more anti-infective agents, to the patient in need of relief from said infection. Methods of uses and composition matters are within the scope of this disclosure.
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p.ex. leucoglucosane, hespéridine, érythromycine, nystatine
A61K 38/14 - Peptides contenant des radicaux saccharide; Leurs dérivés
64.
DETERMINATION OF PERSON STATE RELATIVE TO STATIONARY OBJECT
A first machine learning model is applied to an image of a person and a stationary object to generate a first intermediate image including a simplified pose representation of the person in the image corresponding to a pose of the person. A simplified representation of the stationary object in the image is added to the first intermediate image. The simplified representation includes key points of the stationary object in the image. A second machine learning model is applied to a second intermediate image corresponding to the first intermediate image to determine a state of the person relative to the stationary object in the image as either a first state or a second state.
G06V 20/52 - Activités de surveillance ou de suivi, p.ex. pour la reconnaissance d’objets suspects
G06T 7/73 - Détermination de la position ou de l'orientation des objets ou des caméras utilisant des procédés basés sur les caractéristiques
G06V 10/82 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant les réseaux neuronaux
G06V 20/40 - RECONNAISSANCE OU COMPRÉHENSION D’IMAGES OU DE VIDÉOS Éléments spécifiques à la scène dans le contenu vidéo
G06V 40/10 - Corps d’êtres humains ou d’animaux, p.ex. occupants de véhicules automobiles ou piétons; Parties du corps, p.ex. mains
The present disclosure generally relates to a method for reducing the toxicity of polymyxins as a therapeutic agent comprising the step of coadministration of an aminoglycoside; a method for improving the aerosolization of an aminoglycoside comprising the step of combination formulation with a polymyxin; and a process for manufacturing a dry powder composition comprising a polymyxin and aminoglycoside. Pharmaceutical compositions and methods of treatment for lung infections are within the scope of this invention.
The invention generally relates to systems and methods for analyzing operational status of an electronic instrument. In certain embodiments, the invention provides systems that include a sampling module that operable couples to an electronic instrument in a manner that the sampling module receives a vapor emitted from the electronic instrument, the sampling module comprising an ionization source and one or more mass analyzers to thereby produce a chemical signature of one or more analytes in the vapor; and an analysis module operable coupled to the sampling module to receive the chemical signature of the one or more analytes in the vapor and compare the received chemical signature to a database of known chemical signatures to thereby determine operational status of the electronic instrument.
A fluorescent single molecule emitter simultaneously transmits its identity, location, and cellular context through its emission patterns. A deep neural network (DNN) performs multiplexed single-molecule analysis to enable retrieving such information with high accuracy. The DNN can extract three-dimensional molecule location, orientation, and wavefront distortion with precision approaching the theoretical limit of information content of the image which will allow multiplexed measurements through the emission patterns of a single molecule.
The present invention generally relates to a process of nanoparticle formulations and its composition matter for systemic treatment of sepsis. In particular, this invention discloses a method for preparing tannic acid-ferric nanoparticles, optionally incorporating a component of vitamin D3, coated with zwitterionic chitosan (ZWC) and polymyxin B (PMB). The invention described herein also pertains to pharmaceutical compositions and methods for the treatment of sepsis.
A61K 31/7032 - Composés ayant des radicaux saccharide liés à des composés non-saccharide par des liaisons glycosidiques liés à un polyol, c. à d. composés ayant plusieurs groupes hydroxyle, libres ou estérifiés, y compris le groupe hydroxyle impliqué dans la liaison glycosidique, p.ex. monoglucosyl-diacylglycérides, acide lactobionique, gangliosides
A population of universal natural killer (NK) cells derived from human pluripotent stem cells (hPSCs) and engineered to overexpress the transcription factor ID2, NFIL3, and/or SPI1 and, optionally, an anti-programmed death ligand 1 (PD-L1) chimeric antigen receptor (CAR) and an anti -fluorescein isothiocyanate CAR are provided. Methods of treating cancer in a subject using the population of universal NK cells are also provided.
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
C07K 16/28 - Immunoglobulines, p.ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
C12N 5/0783 - Cellules T; Cellules NK; Progéniteurs de cellules T ou NK
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (USA)
Inventeur(s)
Hu, Chang-Deng
Asberry, Andrew, M.
Cai, Xinpei
Deng, Xuehong
Sims, Hunter
Camacho, Carlos, J.
Dai, Mingji
Abrégé
Disclosed are inhibitors of a protein-protein interaction between protein arginine methyltransferase 5 (PRMT5) and methylosome protein 50 (MEP50) based on isoxazolyl methoxyphenyl derivatives. Further disclosed are pharmaceutical compositions comprising PRMT5:MEP50 inhibitors and methods of inhibiting protein arginine methyltransferase 5 (PRMT5) using PRMT5.MEP50 inhibitors or pharmaceutical compositions comprising PRMT5:MEP50 inhibitors.
A61K 31/422 - Oxazoles non condensés et contenant d'autres hétérocycles
A61K 31/4709 - Quinoléines non condensées contenant d'autres hétérocycles
C07D 215/04 - Composés hétérocycliques contenant les systèmes cycliques de la quinoléine ou de la quinoléine hydrogénée ne comportant pas de liaison entre l'atome d'azote du cycle et un chaînon non cyclique ou ne comportant que des atomes d'hydrogène ou de carbone liés directement à l'atome d'azote du cycle avec uniquement des atomes d'hydrogène ou des radicaux ne contenant que des atomes d'hydrogène et de carbone, liés directement aux atomes de carbone du cycle
C07D 261/08 - Composés hétérocycliques contenant des cycles oxazole-1, 2 ou oxazole-1, 2 hydrogéné non condensés avec d'autres cycles comportant plusieurs liaisons doubles entre chaînons cycliques ou entre chaînons cycliques et chaînons non cycliques avec uniquement des atomes d'hydrogène, des radicaux hydrocarbonés ou des radicaux hydrocarbonés substitués, liés directement aux atomes de carbone du cycle
71.
FOLATE RECEPTOR-TARGETED CONJUGATES, COMPOSITIONS, AND DELIVERY TO THE CENTRAL NERVOUS SYSTEM
A conjugate comprising a ligand that targets a folate receptor linked to an acrolein scavenger drug; a composition comprising same; a method of using the conjugate or the composition to scavenge acrolein, alone or in further combination with other reactive aldehyde species, in a subject with neurotrauma; and a method of delivering an acrolein scavenger or an imaging agent to the central nervous system (CNS) of a patient with inflammation in the CNS.
A61K 47/55 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p.ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique l’agent de modification étant aussi un agent pharmacologiquement ou thérapeutiquement actif, c. à d. le conjugué entier étant un co-médicament, p.ex. un dimère, un oligomère ou un polymère de composés pharmacologiquement ou thérapeutiquement actifs
A61K 31/095 - Composés du soufre, du sélénium ou du tellure, p.ex. thiols
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
72.
TWO-DIMENSIONAL MASS SPECTROMETRY USING ION MICROPACKET DETECTION
The invention generally relates to two-dimensional mass spectrometry using ion micropacket detection. In certain aspects, the invention provides systems including a mass spectrometer having an ion trap and one or more detectors. The system includes a central processing unit (CPU), and storage coupled to the CPU for storing instructions that when executed by the CPU cause the system to: apply one or more scan functions to the ion trap that excite a precursor ion and eject a product ion from the ion trap; and determine a secular frequency of the product ion by detecting micropackets of the product ion as the micropackets are ejected from the ion trap.
Compounds, compositions and methods for reducing off-target toxicity of T cells expressing a chimeric antigen receptor (CAR-T cells) and/or providing enhanced control of CAR-T cell activation, and methods of treating a subject and/or modifying CAR-T cell activity in a subject with cancer.
A61K 47/54 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p.ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
A61K 47/55 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p.ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique l’agent de modification étant aussi un agent pharmacologiquement ou thérapeutiquement actif, c. à d. le conjugué entier étant un co-médicament, p.ex. un dimère, un oligomère ou un polymère de composés pharmacologiquement ou thérapeutiquement actifs
A61K 47/60 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p.ex. les supports ou les additifs inertes; Agents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p.ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique macromoléculaire, p.ex. une molécule oligomérique, polymérique ou dendrimérique obtenu par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p.ex. polyurées ou polyuréthanes le composé organique macromoléculaire étant un oligomère, un polymère ou un dendrimère de polyoxyalkylène, p.ex. PEG, PPG, PEO ou polyglycérol
74.
MUSSEL-INSPIRED TISSUE ADHESIVES AND METHODS OF USE THEREOF
Bioinspired adhesives comprising a macromolecule such as zein and one or more catechol- or gallol-containing compounds are provided. The adhesive can also comprise an iron crosslinker, an interfacial crosslinker, or both an iron crosslinker and an interfacial crosslinker. Methods of manufacturing and using the adhesive are also provided.
Provided are compositions comprising polynucleotides encoding Rps genes, and soybean plants or soybean seeds comprising the compositions and exhibiting resistance to Phytophthora. Additionally, various methods for employing the polynucleotides to increase resistance to Phytophthora are also provided herein.
C12Q 1/6895 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p.ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les plantes, les champignons ou les algues
Methods for facilitating the genesis of photoreceptor rods in a subject by administering a therapeutically effective amount of a therapeutic agent are provided. Other methods are provided for treating retinitis pigmentosa by administering a therapeutically effective dose of therapeutic agents. Methods for producing an in vitro population of progenitor cells and photoreceptor rods generated therefrom are also provided.
A61K 31/403 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p.ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p.ex. sulpiride, succinimide, tolmétine, buflomédil condensés avec des carbocycles, p.ex. carbazole
The invention generally provides systems and methods for performing vessel segmentation from flow data, such as but not limited to 4D flow Magnetic Resonance Imaging (MRI) data. In certain aspects, the systems and methods of the invention may involve receiving flow data representative of flow in a vessel (such as 4D MRI flow data); identifying net flow effects in the flow data (such as 4D MRI flow data) according to a standardized difference of means (SDM) velocity that involves quantifying a ratio between net flow and observed flow pulsatility in each voxel of the received flow data (such as 4D MRI flow data); and identifying voxels with higher SDM velocity values than stationary tissue voxels, thereby performing vessel segmentation from flow data (such as 4D MRI flow data).
G01R 33/563 - Amélioration ou correction de l'image, p.ex. par des techniques de soustraction ou d'établissement de moyenne de matériaux en mouvement, p.ex. angiographie à écoulement contrasté
A61B 5/055 - Détection, mesure ou enregistrement pour établir un diagnostic au moyen de courants électriques ou de champs magnétiques; Mesure utilisant des micro-ondes ou des ondes radio faisant intervenir la résonance magnétique nucléaire [RMN] ou électronique [RME], p.ex. formation d'images par résonance magnétique
G01R 33/56 - Amélioration ou correction de l'image, p.ex. par des techniques de soustraction ou d'établissement de moyenne
A direct reductive amination of aldehydes, ketones, and keto acids with trifluoroacetoxyborane-amines (TFAB-amines), which are mild reductive amination agents prepared by monoacetoxylation of borane-amines; Aromatic and aliphatic lactams are obtained via a tandem reductive amination-cycloamidation of keto acids using TFAB-amine.
C07C 209/28 - Préparation de composés contenant des groupes amino liés à un squelette carboné par alkylation réductive, avec des composés carbonylés, d'ammoniac, d'amines ou de composés ayant des groupes réductibles en groupes amino par réduction avec d'autres agents réducteurs
C07C 213/02 - Préparation de composés contenant des groupes amino et hydroxy, amino et hydroxy éthérifiés ou amino et hydroxy estérifiés liés au même squelette carboné par des réactions impliquant la formation de groupes amino à partir de composés contenant des groupes hydroxy ou des groupes hydroxy éthérifiés ou estérifiés
C07C 253/30 - Préparation de nitriles d'acides carboxyliques par des réactions n'impliquant pas la formation de groupes cyano
C07D 207/267 - Pyrrolidones-2 avec uniquement des atomes d'hydrogène ou des radicaux ne contenant que des atomes d'hydrogène et de carbone, liés directement aux autres atomes de carbone du cycle avec uniquement des atomes d'hydrogène ou des radicaux ne contenant que des atomes d'hydrogène et de carbone, liés directement à l'atome d'azote du cycle
C07D 207/27 - Pyrrolidones-2 avec uniquement des atomes d'hydrogène ou des radicaux ne contenant que des atomes d'hydrogène et de carbone, liés directement aux autres atomes de carbone du cycle avec des radicaux hydrocarbonés substitués liés directement à l'atome d'azote du cycle
C07D 405/06 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne carbonée contenant uniquement des atomes de carbone aliphatiques
C07D 211/76 - Atomes d'oxygène liés en position 2 ou 6
C07D 409/06 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne carbonée contenant uniquement des atomes de carbone aliphatiques
C07D 209/46 - Iso-indoles; Iso-indoles hydrogénés avec un atome d'oxygène en position 1
In some examples in accordance with the present description, an electronic device is provided. The electronic device includes an image sensor and a controller. The controller is to receive multiple images from the image sensor including respective foregrounds and backgrounds. The controller is also to segment the respective foregrounds from the backgrounds. The controller is also to combine the backgrounds to form a fused background. The controller is also to receive a new image including a new image foreground and a new image background. The controller is also to segment the new image foreground from the new image background.
A method for synthesis of Lorazepam in a continuous flow using continuous flow reactor, in which method comprises five steps including N-acylation, diazepine ring closure, imine N- oxidation, Polonovski-type rearrangement, and ester hydrolysis; a green reagent comprising a peroxide reagent and rhenium oxide catalyst for N-oxidation of delorazepam; and an ammonium source combination for the synthesis of delorazepam.
A method of entangling photons in a distributed quantum-based communication system is disclosed which includes generating sets of entangled photon pairs between a plurality of remote nodes (Nodes Ai and Nodes Bi) and a central entangling node (Node C), wherein Nodes Ai and Bi are in both quantum communication and classical communication with Node C, wherein one photon of a first entangled photon pair set is transmitted Node Ai and one photon of a second entangled photon pair set is transmitted to Node Bi, each over the associated quantum channels, and performing Bell-state measurements between the other photon of the first entangled photon pair and the other photon of the second entangled photon pair, such that if the photons arrive at about same time having about same frequency, then the photon pairs are marked as being entangled.
A metal oxide semiconductor (MOS)-based power device includes a semiconductor region, drain and source electrodes, a gate electrode separated from the semiconductor region by SiO2, where the channel length (CHL) has a range of between about 0.6 μm and about 0.5 μm, the silicon dioxide has a corresponding thickness (tox) range of between about 5 nm to about 30 nm, where the CHL has a range of between about 0.5 μm and about 0.4 μm, the tox has a corresponding range of between about 5 nm to about 25 nm, where the CHL has a range of between about 0.4 μm and about 0.3 μm, the tox has a corresponding range of between about 5 nm to about 20 nm, where the CHL has a range of between about 0.3 μm and about 0.2 μm, the tox has a corresponding range of between about 5 nm to about 15 nm.
H01L 29/10 - Corps semi-conducteurs caractérisés par les formes, les dimensions relatives, ou les dispositions des régions semi-conductrices avec des régions semi-conductrices connectées à une électrode ne transportant pas le courant à redresser, amplifier ou commuter, cette électrode faisant partie d'un dispositif à semi-conducteur qui comporte trois électrodes ou plus
H01L 29/78 - Transistors à effet de champ l'effet de champ étant produit par une porte isolée
H01L 29/739 - Dispositifs du type transistor, c.à d. susceptibles de répondre en continu aux signaux de commande appliqués commandés par effet de champ
H01L 29/74 - Dispositifs du type thyristor, p.ex. avec un fonctionnement par régénération à quatre zones
H01L 29/423 - Electrodes caractérisées par leur forme, leurs dimensions relatives ou leur disposition relative ne transportant pas le courant à redresser, à amplifier ou à commuter
C07D 417/14 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre et d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant au moins trois hétérocycles
C07D 403/12 - Composés hétérocycliques contenant plusieurs hétérocycles, comportant des atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
C07D 413/14 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes d'azote et d'oxygène comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
C07D 401/12 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
A method of eliminating a gilt from selection for breeding comprising (i) obtaining a vaginal lipidome profile from a gilt at around the time of weaning and (ii) using the vaginal lipidome profile to assign the gilt as probable fertile or infertile; a method of analyzing a lipidome profile of a gilt vaginal swab comprising (i) receiving a vaginal swab obtained from a gilt at around the time of weaning and (ii) analyzing, or having analyzed, lipids obtained from the vaginal swab, and (iii) determining, or having determined, decreases/increases in lipid levels compared to normal; and a kit for obtaining a vaginal swab from a gilt.
G01N 33/92 - Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique faisant intervenir des lipides, p.ex. le cholestérol
85.
NANODEVICE, METHOD OF MAKING THE SAME, AND METHOD OF USING THE SAME
A nanodevice provides for electric-field control of magnon-QSD interactions. The nanodevice includes a ferroelectric substrate, a ferromagnetic material disposed over the ferroelectric substrate, and a nanodiamond including an ensemble of nitrogen-vacancy (NV) spins, each NV magnetically interfacing with the ferromagnetic material. An electric field is measured by applying a voltage across the ferroelectric substrate and the ferromagnetic material, changing a magnon excitation spectrum of the ferromagnetic material with respect to an electron spin resonance frequency of the ensemble of NV spins, and measuring a relaxation rate of the ensemble of NV spins.
in plantain planta in planta includes co- incubating, post-anthesis, a cereal inflorescence of developing embryos with an inoculation medium comprising a transgene-modified Agrobacterium; collecting, upon the cereal inflorescence reaching maturity, seeds produced from at least a portion of the developing embryos; and selecting one or more transgenic seeds from among the collected seeds.
A01H 5/00 - Angiospermes, c. à d. plantes à fleurs, caractérisées par leurs parties végétales; Angiospermes caractérisées autrement que par leur taxonomie botanique
87.
METHODS FOR FORMING MICROSCALE AND/OR NANOSCALE STRUCTURES ON SURFACES AND DEVICES INCLUDING BIOMEDICAL DEVICES HAVING SURFACES WITH SUCH STRUCTURES
Methods for forming micro- and/or nano-structures on the surfaces of a device and devices made thereby. The methods include exposing the surfaces of the device having an initial microstructure to an oxidizing environment at a first elevated temperature so as to form a first oxide scale on the device surfaces, exposing the first oxide scale to a reducing agent at a second elevated temperature so as to convert or partially convert the first oxide scale into a composite scale that includes a second oxide and a first metal, and exposing the composite scale to a dissolution agent that selectively dissolves part or all of the second oxide so as to yield a porous surface layer that includes the first metal.
A method for making an optically active P2-ligand precursor comprising converting D-xylose or a derivative thereof or D-glucose or a derivative thereof to the optically active P2-ligand precursor.
A direct current (DC) electrical panel (DC Combiner) is disclosed which includes a plurality of input pairs of positive and negative inputs, each input pair of the plurality of input pairs is configured to provide a positive DC input at a predefined voltage and a negative DC return, each positive input is coupled to a protection circuit whereby each such positive input is isolated from other positive inputs of the plurality of input pairs, thereby generating a protected input, each protected input is coupled to a busbar, and the busbar coupled to a plurality of switched circuits via a breaker switch in line with a protected input.
H02B 1/20 - Schémas de barres omnibus ou d'autres fileries, p.ex. dans des armoires, dans les stations de commutation
H02B 1/18 - Dispositions ou aménagement de fusibles
H02H 3/16 - Circuits de protection de sécurité pour déconnexion automatique due directement à un changement indésirable des conditions électriques normales de travail avec ou sans reconnexion sensibles à un courant de défaut à la terre ou à la masse
91.
PLATINUM COMPLEXES, RELATED COMPOSITIONS, AND USES THEREOF IN CYANIDE COUNTERMEASURES
Platinum-thioester complexes, compositions comprising such platinum-thioester complexes, methods of treating cyanide poisoning and/or cyanide exposure with the same and related combinations therapies and kits therefore.
Systems and methods for measuring web tension distribution in roll-to-roll processes, for example, such as R2R processes employed in the fabrication of printed devices. Such systems and methods entail a web that travels between first and second rollers in a longitudinal direction of the web, inducing tension in the web in the longitudinal direction thereof such that tension is present in a flexible substrate of the web between the first and second rollers, and operating the system to determine an average tension and linear variation of tension present in the flexible substrate resulting from the tension induced in the web inducing a nonuniform tension distribution in the flexible substrate between the first and second rollers. The systems and methods utilize one or more devices that induce deflection in the web between the first and second rollers.
G01L 5/04 - Appareils ou procédés pour la mesure des forces, du travail, de la puissance mécanique ou du couple, spécialement adaptés à des fins spécifiques pour la mesure de la tension dans les éléments flexibles, p.ex. dans les cordages, les câbles, les fils métalliques, les filaments, les courroies ou les bandes
B65H 23/04 - Positionnement, tension, suppression des à-coups ou guidage des bandes longitudinal
In some examples in accordance with the present description, an electronic device is provided. The electronic device includes a controller to implement an image segmentation process. The controller is to obtain color information of an image. The controller also is to obtain depth information of the image. The controller also is to determine a depth of a face represented in the color information. The controller also is to segment a foreground of the image from a background of the image according to the color information and the depth information based on the depth of the face.
Systems and methods for measuring web tension distribution in roll-to-roll processes, for example, such as R2R processes employed in the fabrication of printed devices. Such systems and methods entail a web that travels between first and second rollers in a longitudinal direction of the web, inducing tension in the web in the longitudinal direction thereof such that tension is present in a flexible substrate of the web between the first and second rollers, and operating the system to determine an average tension and linear variation of tension present in the flexible substrate resulting from the tension induced in the web inducing a nonuniform tension distribution in the flexible substrate between the first and second rollers. The systems and methods utilize one or more devices that induce deflection in the web between the first and second rollers.
G01L 5/04 - Appareils ou procédés pour la mesure des forces, du travail, de la puissance mécanique ou du couple, spécialement adaptés à des fins spécifiques pour la mesure de la tension dans les éléments flexibles, p.ex. dans les cordages, les câbles, les fils métalliques, les filaments, les courroies ou les bandes
B65H 23/04 - Positionnement, tension, suppression des à-coups ou guidage des bandes longitudinal
97.
PLANT CELL CHROMOSOME DOUBLING BY APPLICATION OF ELECTROMAGNETIC FIELD
Disclosed are methods for the doubling of a plant cell's chromosome by applying an electromagnetic field and methods for obtaining a doubled-haploid plant cell. In some embodiments, the plant cell is selected from the group comprising maize, rice, tomato, and tobacco. Also disclosed is an apparatus for applying an electromagnetic field to a plant cell.
The present disclosure relates to a stage-specific process for manufacturing a population of neutrophils, such as chimeric antigen receptor-expressing (CAR-expressing) neutrophils (e.g., T cells and natural killer (NK) cells), from human pluripotent stem cells (hPSCs) using defined media and related compositions, kits, and methods of use (e.g., targeted cancer immunotherapy). Stage-specific processes for generating neutrophils and chimeric antigen receptor (CAR) neutrophils from human pluripotent stem cells (hPSCs) using chemically defined, feeder-free platforms and stage-specific morphogens; cell lines; pharmaceutical compositions; a method of treating cancer; and a kit are within the scopes of this disclosure.
The present disclosure relates to adhesive compositions made from the reaction product of plant protein and phenolics, and method of making and using the adhesive compositions. A maximum bonding strength of 7.8±1.5 MPa was obtained using only 1 weight % tannic acid in a zein matrix of pH=7 and cured in 120° C.
